UPC Analytics
DEEN
Übersicht · Eingereicht:

UPC_APP_17784/2025

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

Prozessuale & UnteranträgeRücknahmeanträgeMilan CDApplication Rop 265Vergleich erfolgt: Vor Hauptsache
  • 2025-04-22ZurückgenommenproceduralApplication Rop 265

    Order by Milan Central Division (UPC_CFI_687/2024, 22 April 2025) permitting Pfizer's withdrawal of the revocation action and counterclaim for revocation against GlaxoSmithKline's EP 4 183 412 (RSV F protein vaccine), and permitting GlaxoSmithKline to withdraw its patent amendment application. 60% court fee reimbursement was granted; each party bears its own costs.